Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDerwent London Regulatory News (DLN)

Share Price Information for Derwent London (DLN)

Share Price is delayed by 15 minutes
Get Live Data
2,006.00    60.00 (3.08%)
Bid:
2,000.00
Ask:
2,002.00
Spread: 2.00 (0.10%)
Market Cap: £2.23b
DLN Live PriceLast checked at - London Stock Exchange

Intraday Derwent London Share Chart

Directorate change

22 Jan 2026 09:00

RNS Number : 9492P
Derwent London PLC
22 January 2026
 

 

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION

 

Derwent London plc ("Derwent London" / "the Group")

PAUL WILLIAMS, CHIEF EXECUTIVE, TO RETIRE

Derwent London today announces that Paul Williams has informed the Board of his intention to retire as Chief Executive and Director of the Company.

Paul will remain in his role until his successor is in place at which point he will step down from the Board.

Paul's career at Derwent began shortly after the Company was founded in 1984. He was appointed as an Executive Director in 1998, with responsibility for leasing, asset management and development, and subsequently became Chief Executive in 2019.

A thorough process to appoint a successor, led by the Chairman Mark Breuer, will commence immediately.

Mark Breuer, Chairman, commented: 

"I would like to thank Paul for his dedication and commitment over the last 38 years. During his distinguished career, including his tenure as Chief Executive, he has made an outstanding contribution to Derwent London. With its market leading position, ongoing commitment to capital recycling and significant development pipeline, Derwent London is well placed to create significant value for shareholders."

Paul Williams, Chief Executive, said:

"It has been a huge privilege to have been part of the Derwent story and to have had the opportunity to lead the business over the last six years. I am very proud of what we have achieved, positioning the business with world class assets in prime locations across London, attracting sustained and strong occupational demand. I would like to thank my fellow directors and all the team for their continued hard work and support. I remain fully focused on driving the performance of the business until my successor is in place."

Information equivalent to that required under section 430(2B) of the UK Companies Act 2006 will be made available on the Company's website at the time Paul Williams steps down from the Board and in the Company's 2025 Directors' Remuneration Report.

For further information, please contact:

Derwent London

Tel: +44 (0)20 3478 4217 (Robert Duncan)

Mark Breuer, Chairman

David Lawler, Company Secretary

Robert Duncan, Head of Investor Relations

Brunswick Group

Tel: +44 (0)20 7404 5959

 

 

Simon Sporborg

Nina Coad

Notes to editors

Derwent London plc

Derwent London plc owns a commercial real estate portfolio predominantly in central London valued at £5.2 billion as at 30 June 2025, making it the largest London office-focused real estate investment trust (REIT).

Our experienced team has a long track record of creating value throughout the property cycle by regenerating our buildings via redevelopment or refurbishment, effective asset management and capital recycling. We typically acquire central London properties off-market with low capital values and modest rents in improving locations, most of which are either in the West End or City Borders. We capitalise on the unique qualities of each of our properties - taking a fresh approach to the regeneration of every building with a focus on anticipating tenant requirements and an emphasis on design. Reflecting and supporting our long-term success, the business has a strong balance sheet with modest leverage, a robust income stream and flexible financing.

We are frequently recognised in industry awards for the quality, design and innovation of our projects. Landmark buildings in our 5.3 million sq ft portfolio include 25 Baker Street W1, 1 Soho Place W1, 80 Charlotte Street W1, Brunel Building W2, White Collar Factory EC1, Angel Building EC1 and Tea Building E1.

As part of our commitment to lead the industry in mitigating climate change, Derwent London has committed to becoming a net zero carbon business by 2030, publishing its pathway to achieving this goal in 2020. Our science-based carbon targets have been validated by the Science Based Targets initiative (SBTi). In 2013, we launched a voluntary Community Fund which to date has supported 180 community projects in central London.

The Company is a public limited company, which is listed on the London Stock Exchange and incorporated and domiciled in the UK. The address of its registered office is 25 Savile Row, London, W1S 2ER.

For further information see www.derwentlondon.com or follow us on LinkedIn.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAGIGDBIBDDGLD
Date   Source Headline
14th Jun 20183:55 pmRNSSony Pictures Take Leading Role At Brunel Building
31st May 20181:00 pmRNSTotal Voting Rights
25th May 20183:00 pmRNSBlock listing Interim Review
18th May 201812:15 pmRNSResults of 2018 Annual General Meeting
16th May 201811:00 amRNSAdditional Listing
15th May 20185:30 pmRNSBondholders' meeting
10th May 20187:00 amRNSQ1 2018 Business Update
3rd May 20184:21 pmRNSAdjustment to Conversion Price
30th Apr 20186:20 pmRNSTotal Voting Rights
20th Apr 20185:30 pmRNSDirector/PDMR Shareholding
18th Apr 20183:30 pmRNSAnnual Report & Accounts 2017 and Notice of AGM
4th Apr 20184:00 pmRNSDirector/PDMR Shareholding
29th Mar 20185:00 pmRNSTotal Voting Rights
26th Mar 20181:30 pmRNSDirector/PDMR Shareholding
23rd Mar 20189:30 amRNSDirector/PDMR Shareholding
20th Mar 201811:00 amRNSBlock listing Interim Review
16th Mar 201811:00 amRNSDirector Declaration
14th Mar 201811:00 amRNSAdditional Listing
8th Mar 201812:30 pmRNSDirector Declaration
7th Mar 20181:30 pmRNSDirector/PDMR Shareholding
2nd Mar 201810:00 amRNSDirector/PDMR Shareholding
28th Feb 20185:30 pmRNSTotal Voting Rights
27th Feb 20187:00 amRNSDerwent London: Results for Year Ended 31 Dec 2017
31st Jan 201811:00 amRNSTotal Voting Rights
25th Jan 201811:00 amRNSAdditional Listing
17th Jan 201810:00 amRNSCrossrail hands over major West End site
2nd Jan 20185:00 pmRNSDirector/PDMR Shareholding
2nd Jan 20187:00 amRNSTotal Voting Rights
19th Dec 20175:30 pmRNSDirector/PDMR Shareholding
12th Dec 201711:00 amRNSAdditional Listing
4th Dec 201710:00 amRNSDirector Declaration
30th Nov 20175:00 pmRNSTotal Voting Rights
27th Nov 20175:00 pmRNSBlock listing Interim Review
22nd Nov 20179:00 amRNSDirectorate Change
21st Nov 201712:30 pmRNSDerwent London Secures West End Planning Consents
9th Nov 20177:00 amRNSQ3 2017 Business Update
31st Oct 20175:00 pmRNSTotal Voting Rights
10th Oct 20175:30 pmRNSDirector/PDMR Shareholding
2nd Oct 20174:45 pmRNSCompany Secretary Change
2nd Oct 201711:50 amRNSTotal Voting Rights
26th Sep 20174:40 pmRNSBlock listing Interim Review
11th Sep 20177:00 amRNSDerwent London secures further major pre-lets
10th Aug 20177:01 amRNSLetting at White Chapel Building
10th Aug 20177:00 amRNSInterim results for the half year ended 30 June 17
1st Aug 20176:05 pmRNSHolding(s) in Company
3rd Jul 20179:59 amRNSVOTING RIGHTS AND CAPITAL
3rd Jul 20177:00 amRNSDerwent London sells The Copyright Building
22nd Jun 20173:15 pmRNSHolding(s) in Company
6th Jun 20174:20 pmRNSBondholders' meeting
6th Jun 20174:15 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.